Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × Doxorubicin × Clear all

NCT00484601 2019-02-11

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Phase 2 Terminated

Nasopharyngeal Carcinoma